-
2
-
-
78049485263
-
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
-
Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
-
(2010)
Int J Cancer
, vol.127
, pp. 2893-2917
-
-
Ferlay, J.1
Shin, H.R.2
Bray, F.3
-
3
-
-
69949162760
-
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma
-
Mok TS, Wu YL, Thongprasert S et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009; 361: 947-957.
-
(2009)
N Engl J Med
, vol.361
, pp. 947-957
-
-
Mok, T.S.1
Wu, Y.L.2
Thongprasert, S.3
-
4
-
-
79960889662
-
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase3 study
-
Zhou C, Wu YL, Chen G et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase3 study. Lancet Oncol 2011; 12: 735-742.
-
(2011)
Lancet Oncol
, vol.12
, pp. 735-742
-
-
Zhou, C.1
Wu, Y.L.2
Chen, G.3
-
5
-
-
34547638047
-
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
-
Soda M, Choi YL, Enomoto M et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007; 448: 561-566.
-
(2007)
Nature
, vol.448
, pp. 561-566
-
-
Soda, M.1
Choi, Y.L.2
Enomoto, M.3
-
6
-
-
84863338079
-
ROS1 rearrangements define a unique molecular class of lung cancers
-
Bergethon K, Shaw AT, Ou SH et al. ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol 2012; 30: 863-870.
-
(2012)
J Clin Oncol
, vol.30
, pp. 863-870
-
-
Bergethon, K.1
Shaw, A.T.2
Ou, S.H.3
-
7
-
-
84857929267
-
KIF5B-RET fusions in lung adenocarcinoma
-
Kohno T, Ichikawa H, Totoki Y et al. KIF5B-RET fusions in lung adenocarcinoma. Nat Med 2012; 18: 375-377.
-
(2012)
Nat Med
, vol.18
, pp. 375-377
-
-
Kohno, T.1
Ichikawa, H.2
Totoki, Y.3
-
8
-
-
2342471392
-
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
-
Lynch TJ, Bell DW, Sordella R et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004; 350: 2129-2139.
-
(2004)
N Engl J Med
, vol.350
, pp. 2129-2139
-
-
Lynch, T.J.1
Bell, D.W.2
Sordella, R.3
-
9
-
-
80052806086
-
Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)
-
Cui JJ, Tran-Dube M, Shen H et al. Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK). J Med Chem 2011; 54: 6342-6363.
-
(2011)
J Med Chem
, vol.54
, pp. 6342-6363
-
-
Cui, J.J.1
Tran-Dube, M.2
Shen, H.3
-
10
-
-
44849126091
-
Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors
-
McDermott U, Iafrate AJ, Gray NS et al. Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors. Cancer Res 2008; 68: 3389-3395.
-
(2008)
Cancer Res
, vol.68
, pp. 3389-3395
-
-
McDermott, U.1
Iafrate, A.J.2
Gray, N.S.3
-
11
-
-
78049425319
-
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer
-
Kwak EL, Bang YJ, Camidge DR et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010; 363: 1693-1703.
-
(2010)
N Engl J Med
, vol.363
, pp. 1693-1703
-
-
Kwak, E.L.1
Bang, Y.J.2
Camidge, D.R.3
-
12
-
-
84857985225
-
RET, ROS1 and ALK fusions in lung cancer
-
Takeuchi K, Soda M, Togashi Y et al. RET, ROS1 and ALK fusions in lung cancer. Nat Med 2012; 18: 378-381.
-
(2012)
Nat Med
, vol.18
, pp. 378-381
-
-
Takeuchi, K.1
Soda, M.2
Togashi, Y.3
-
13
-
-
84865441368
-
Identifying and targeting ROS1 gene fusions in non-small cell lung cancer
-
Davies KD, Le AT, Theodoro MF et al. Identifying and targeting ROS1 gene fusions in non-small cell lung cancer. Clin Cancer Res 2012; 18: 4570-4579.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 4570-4579
-
-
Davies, K.D.1
Le, A.T.2
Theodoro, M.F.3
-
14
-
-
0023477402
-
Expression and rearrangement of the ROS1 gene in human glioblastoma cells
-
Birchmeier C, Sharma S, Wigler M. Expression and rearrangement of the ROS1 gene in human glioblastoma cells. Proc Natl Acad Sci USA 1987; 84: 9270-9274.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 9270-9274
-
-
Birchmeier, C.1
Sharma, S.2
Wigler, M.3
-
15
-
-
33747189468
-
A prospective replication study of five gene variants previously associated with risk of myocardial infarction
-
Zee RY, Michaud SE, Hegener HH et al. A prospective replication study of five gene variants previously associated with risk of myocardial infarction. J Thromb Haemost 2006; 4: 2093-2095.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 2093-2095
-
-
Zee, R.Y.1
Michaud, S.E.2
Hegener, H.H.3
-
16
-
-
36849065315
-
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
-
Rikova K, Guo A, Zeng Q et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007; 131: 1190-1203.
-
(2007)
Cell
, vol.131
, pp. 1190-1203
-
-
Rikova, K.1
Guo, A.2
Zeng, Q.3
-
17
-
-
79251579592
-
Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma
-
Gu TL, Deng X, Huang F et al. Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One 2011; 6: e15640.
-
(2011)
PLoS One
, vol.6
-
-
Gu, T.L.1
Deng, X.2
Huang, F.3
-
18
-
-
82755170504
-
Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours
-
Birch AH, Arcand SL, Oros KK et al. Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours. PLoS One 2011; 6: e28250.
-
(2011)
PLoS One
, vol.6
-
-
Birch, A.H.1
Arcand, S.L.2
Oros, K.K.3
-
19
-
-
79551538094
-
Frequencies of ALK and ROS in NSCLC FFPE tumor samples utilizing a highly specific immunohistochemistry-based assay and FISH analysis
-
abstr 10536
-
Rimkunas V, Crosby K, Kelly M et al. Frequencies of ALK and ROS in NSCLC FFPE tumor samples utilizing a highly specific immunohistochemistry-based assay and FISH analysis. J Clin Oncol 2010; 28: 15s (suppl; abstr 10536).
-
(2010)
J Clin Oncol
, vol.28
, Issue.SUPPL
-
-
Rimkunas, V.1
Crosby, K.2
Kelly, M.3
-
20
-
-
84865089246
-
Analysis of receptor tyrosine kinase ROS1- positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion
-
Rimkunas VM, Crosby KE, Li D et al. Analysis of receptor tyrosine kinase ROS1- positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion. Clin Cancer Res 2012; 18: 4449-4457.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 4449-4457
-
-
Rimkunas, V.M.1
Crosby, K.E.2
Li, D.3
-
21
-
-
84866434919
-
Genomic landscape of non-small cell lung cancer in smokers and never-smokers
-
Govindan R, Ding L, Griffith M et al. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 2012; 150: 1121-1134.
-
(2012)
Cell
, vol.150
, pp. 1121-1134
-
-
Govindan, R.1
Ding, L.2
Griffith, M.3
-
22
-
-
84868309107
-
The transcriptional landscape and mutational profile of lung adenocarcinoma
-
Seo JS, Ju YS, Lee WC et al. The transcriptional landscape and mutational profile of lung adenocarcinoma. Genome Res 2012; 22: 2109-2119.
-
(2012)
Genome Res
, vol.22
, pp. 2109-2119
-
-
Seo, J.S.1
Ju, Y.S.2
Lee, W.C.3
-
23
-
-
84873697461
-
Prevalence and clinical outcomes for patients with ALK gene rearrangement in Europe: preliminary results from the European Thoracic Oncology Platform Lungscape Project
-
(abstr 167O)
-
Blackhall F, Peters S, Ken KM et al. Prevalence and clinical outcomes for patients with ALK gene rearrangement in Europe: preliminary results from the European Thoracic Oncology Platform Lungscape Project. Ann Oncol 2012; 23 (suppl 9): ix73 (abstr 167O).
-
(2012)
Ann Oncol
, vol.23
, Issue.SUPPL 9
-
-
Blackhall, F.1
Peters, S.2
Ken, K.M.3
-
24
-
-
82355161909
-
Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers
-
Li C, Fang R, Sun Y et al. Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers. PLoS One 2011; 6: e28204.
-
(2011)
PLoS One
, vol.6
-
-
Li, C.1
Fang, R.2
Sun, Y.3
-
25
-
-
84871784888
-
ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms
-
Lee HJ, Seol HS, Kim JY et al. ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms. Ann Surg Oncol 2013; 20: 200-208.
-
(2013)
Ann Surg Oncol
, vol.20
, pp. 200-208
-
-
Lee, H.J.1
Seol, H.S.2
Kim, J.Y.3
-
26
-
-
84866894408
-
Comprehensive genomic characterization of squamous cell lung cancers
-
Hammerman PS, Hayes DN, Wilkerson MD et al. Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012; 489: 519-525.
-
(2012)
Nature
, vol.489
, pp. 519-525
-
-
Hammerman, P.S.1
Hayes, D.N.2
Wilkerson, M.D.3
|